Climate Change Data Portal
DOI | 10.1080/10937404.2018.1440902 |
In vivo and in vitro methods for evaluating soil arsenic bioavailability: relevant to human health risk assessment | |
Bradham, Karen D.1; Diamond, Gary L.2; Burgess, Michele3; Juhasz, Albert4; Klotzbach, Julie M.2; Maddaloni, Mark5; Nelson, Clay1; Scheckel, Kirk6; Serda, Sophia M.7; Stifelman, Marc8; Thomas, David J.9 | |
发表日期 | 2018 |
ISSN | 1093-7404 |
卷号 | 21期号:2页码:83-114 |
英文摘要 | Arsenic (As) is the most frequently occurring contaminant on the priority list of hazardous substances, which lists substances of greatest public health concern to people living at or near U.S. National Priorities List site. Accurate assessment of human health risks from exposure to As-contaminated soils depends on estimating its bioavailability, defined as the fraction of ingested As absorbed across the gastrointestinal barrier and available for systemic distribution and metabolism. Arsenic bioavailability varies among soils and is influenced by site-specific soil physical and chemical characteristics and internal biological factors. This review describes the state-of-the science that supports our understanding of oral bioavailability of soil As, the methods that are currently being explored for estimating soil As relative bioavailability (RBA), and future research areas that could improve our prediction of the oral RBA of soil As in humans. The following topics are addressed: (1) As soil geochemistry; (2) As toxicology; (3) in vivo models for estimating As RBA; (4) in vitro bioaccessibility methods; and (5) conclusions and research needs. |
语种 | 英语 |
WOS记录号 | WOS:000428055900003 |
来源期刊 | JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS |
来源机构 | 美国环保署 |
文献类型 | 期刊论文 |
条目标识符 | http://gcip.llas.ac.cn/handle/2XKMVOVA/57975 |
作者单位 | 1.US EPA, Publ Hlth Chem Branch, Exposure Methods & Measurements Div, Natl Exposure Res Lab,Off Res & Dev, Res Triangle Pk, NC 27711 USA; 2.SRC Inc, North Syracuse, NY USA; 3.US EPA, Sci Policy Branch, Off Superfund Remediat & Technol Innovat, Off Land & Emergency Management, Arlington, VA USA; 4.Univ South Australia, Future Ind Inst, Adelaide, SA, Australia; 5.US EPA, Reg 2, New York, NY USA; 6.US EPA, Land Remediat & Pollut Control Div, Natl Risk Management Res Lab, Off Res & Dev, Cincinnati, OH 45268 USA; 7.US EPA, Reg 9, San Francisco, CA USA; 8.US EPA, Reg 10, Seattle, WA USA; 9.US EPA, Pharmacokinet Branch, Integrated Syst Toxicol Div, Natl Hlth & Environm Effects Res Lab,Off Res & De, Res Triangle Pk, NC 27711 USA |
推荐引用方式 GB/T 7714 | Bradham, Karen D.,Diamond, Gary L.,Burgess, Michele,et al. In vivo and in vitro methods for evaluating soil arsenic bioavailability: relevant to human health risk assessment[J]. 美国环保署,2018,21(2):83-114. |
APA | Bradham, Karen D..,Diamond, Gary L..,Burgess, Michele.,Juhasz, Albert.,Klotzbach, Julie M..,...&Thomas, David J..(2018).In vivo and in vitro methods for evaluating soil arsenic bioavailability: relevant to human health risk assessment.JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS,21(2),83-114. |
MLA | Bradham, Karen D.,et al."In vivo and in vitro methods for evaluating soil arsenic bioavailability: relevant to human health risk assessment".JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS 21.2(2018):83-114. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。